The high level of clinical heterogeneity in HPP is typically attributed to the >460 ALPL variants that have been identified to date, although the overall correlation between genotype and phenotype in HPP is limited (Del Angel et al., 2020; Farman et al., 2024; Mornet, 2018). Here, ALPL is linked to hypophosphatasia.